logo
Select company
Select metric
1.64Cash Ratio
VS
Market
77
Sector
57
Industry
43
History
32
$ 27.98Close
$ 6.28 - $ 27.98 52-Week Range
Ticker Information

Ticker

NTLA

Company Name

INTELLIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INTELLIA THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NTLA - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 156.17M1.64$ 95.5M
3/31/2025$ 126.88M1.13$ 112.59M
12/31/2024$ 189.18M1.71$ 110.85M
9/30/2024$ 120.5M1.14$ 105.68M
6/30/2024$ 130.85M1.25$ 105.09M
3/31/2024$ 171.98M1.76$ 97.91M
12/31/2023$ 226.75M1.97$ 115.21M
9/30/2023$ 168.03M1.83$ 91.95M
6/30/2023$ 171.81M1.72$ 99.85M
3/31/2023$ 294.15M2.85$ 103.38M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INTELLIA THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 3.22.
  • Over the past 5 years, INTELLIA THERAPEUTICS INC's average Cash Ratio has been 1.93.
  • The median Cash Ratio for INTELLIA THERAPEUTICS INC during this period was 1.74
  • INTELLIA THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 4.14.
  • The lowest Cash Ratio recorded by INTELLIA THERAPEUTICS INC in the same timeframe 0.98

INTELLIA THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
ABCL : ABCELLERA BIOLOGICS INC 1.75EYPT : EYEPOINT PHARMACEUTICALS INC 2.15ZVRA : ZEVRA THERAPEUTICS INC 1.65BEAM : BEAM THERAPEUTICS INC 1.66MGTX : MEIRAGTX HOLDINGS PLC 0.64SNDX : SYNDAX PHARMACEUTICALS INC 0.96LXRX : LEXICON PHARMACEUTICALS INC 1.45OCUL : OCULAR THERAPEUTIX INC 9.15WVE : WAVE LIFE SCIENCES LTD 2.39SCPH : SCPHARMACEUTICALS INC 2

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for INTELLIA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 179.75M ] / LiabilitesC [ $ 55.87M ]
(=) Cash Ratio [ 3.22 ]

NTLA - Cash Ratio, Last 5 years

0.98

Minimum

Dec 31, 2021

4.14

Maximum

Dec 31, 2022

1.93

Average

1.74

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63